Sign in

NCT03949387Completed

Functional Electrical Stimulation Cycling for Managing Mobility Disability in People with Multiple Sclerosis

Source: ClinicalTrials.gov · Last updated 24 Dec 2024

Brief summary (registry, in English)

Mobility impairment is one of the most common, poorly managed, and life altering consequences of MS. Current therapies for managing MS do not prevent the long-term accumulation of mobility impairment, highlighting the need for alternative strategies that prevent or slow progressive mobility disability. The proposed trial will test the efficacy and lasting effects of functional electrical stimulation (FES) cycling as an exercise-based rehabilitation strategy for managing mobility impairment and associated consequences in MS.

Status (registry)
Completed
Study type
Interventional
Enrollment
10 (actual)
First submitted
6 May 2019
Start date
16 Oct 2019
Primary completion date
28 Oct 2024
Lead sponsor
University of Ottawa
NCT number
NCT03949387

What you commit to

  • Study type: Interventional
  • Participants enrolled: 10
  • From 16 Oct 2019 to the primary completion date, 28 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • presence of any contraindication to FES including epilepsy, a pacemaker, implanted defibrillator, unstable fracture, or pregnancy
  • diagnosis of other neurological condition(s)

Other

  • participation in FES cycling exercise or other mobility-based exercise rehabilitation program within the past 6 months
  • current use of dalfampridine within the past month

Who the study is looking for

  • diagnosis of multiple sclerosis
  • relapse free in the past 30 days
  • stable course of disease-modifying therapies over the past 6 months
  • ability to communicate in English
  • willing to come to the University of Ottawa to complete testing and training sessions
  • EDSS score 5.0 - 7.0
  • asymptomatic based on a physical activity pre-participation screening tool

Age in the registry: 18 years to 64 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
University of Ottawa
Coordinator of this site? Confirm its status
OttawaCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.